Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
The european centre for disease prevention and control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use
Zarb, P., Coignard, B., Griskeviciene, J., Muller, A., Vankerckhoven, V., Weist, K., Goossens, M.M., Vaerenberg, S., Hopkins, S., Catry, B., Monnet, D.L., Goossens, H., Suetens, C.
Antimicrobial resistance 2010: Global attention on carbapenemase-producing bacteria
Monnet, D.L., Suetens, C., Earnshaw, S., Gagliotti, C., Griskeviciene, J., Heuer, O.E., Khazeeva, E., Kleinkauf, N., Liljestedt, E., Magiorakos, A.-P., Santos, F., Struelens, M.J., Weber, J.T., Weist, K.
ECDC collects, analyses and disseminates surveillance data on communicable diseases and related special health issues from all European Union (EU) Member States and two of the three remaining European Economic Area (EEA) countries (Iceland and Norway). Data submission and subsequent validation is the responsibility of European networks of disease experts nominated by Member States and coordinated by ECDC through its disease programmes.